Rheumatolo
oys the challenges
his specialty

Dr. Lubetsky chose rheumatol-
ogy for the challenge of the
variety of diseases treated by
the specialty. After attending
medical school at Wayne State
University, he spent his intern-
ship, residency and fellowship
at Henry Ford Hospital in
Detroit, and has been with the
Henry Ford Health System for
25 years.

Rheumatologists treat arthritis,
with osteo- and rheumatoid
arthritis being the most common.
It's estimated that 15 percent of
all Americans have some form of
arthritis, with percent of the
total population having
rheumatoid arthritis. These
specialists also see patients with
certain autoimmune diseases,
musculoskeletal pain disorders,
such as fibromyalgia, and
osteoporosis.

Rheumatic diseases and
syndromes constitute more
than half of the conditions seen
in the office of an internist.
Generally, patients are referred
to rheumatologists through
their primary care physician.

"Many of the diseases in
rheumatology are chronic,"
Dr. Lubetsky says. "With the
high frequency of visits neces-
sary for these conditions, I'm
able to develop long-term
relationships with my patients."

The challenge is that many of
the diseases are difficult to
diagnose. Dr. Lubetsky says it's
important to follow patients for
a while, to be able to arrive at
a diagnosis. As the disease
changes and evolves over time,
an individualized treatment pro-
gram is tailored to each patient.

Editorial

Editor

ahorwitzCa)thejewishnews.com

Robert A. Sklar

kevinjewish.com

Advertising Sales

Advertising Director

Meg Lyczak

mlyczak@thejewishnews.com
Account Executives

Wendy Rusty
Elizabeth Friedman
Jan Haskell
Kathy Johnson
Melissa Litvin
Heidi Martin
Rick Nessel
Dharlene Norris
Caren Osrin
June Thiesmeyer

rsklar®thejewishnews.com

Marc Bakst
Marion Freedman

News/Life/Business Group:

Sally Krugel

Alan Hitsky

Associate Editor
ahitsky®thejewishnews.com

Keri Guten Cohen

Story Development Editor
kcohen@thejewishnews.com

Elizabeth Applebaum

Contributing Editor
eapplebaum@thejewishnews.com

Harry Kirsbaum

Lila Lazarus
Steven Schanes

David Techner

Gary Torgow

Jeff Weingarten, M.D.

Young Adult Advisory Board

Gayle Friedman Gold
Jordan Glass
Robin Schwartz
Brad "Bubba" Urdan

Published by:

Jewish Renaissance Media

Staff Writer
sdorfman@thejewishnews.com

Chairman

Associate Account Executive

Arts Group:

Arthur M. Horwitz

Aurora Colak

Gail Zimmerman

Chief Operating Officer

F. Kevin Browett

Business Offices

Arts Editor
gzirnmerman@thejewishnews.com

Billing Coordinator

Pamela Turner

Collection Analyst

Hazel Bender

Creative Services

creative@thejewishnews.com
Production Director

Michelle Sheridan

Creative Director

Deborah Schultz

Creative Services

Cathy Ciccone
Nicole Browett
Anne Lada
Donna Pace
Edyta Skiba
Todd Skiba
Melissa Woodington

Traffic Coordinator

Wilhelmina Vickers

Photography

Staff Photographers

Angie Baan
Brett Mountain

Michael H. Steinhardt

President

Platinum Group:

Lynne Konstantin

Editor
lkonstantin@thejewishnews.com

Gail Zimmerman

Executive Editor
gzimmerman@thejewishnews.com

Copy Team Group:

David Sachs

Senior Copy Editor
dsachsWthejewishnews.com

Sy Manello

Copy Team Assistant
smanelloWthejewishnews.com

Leonard Poger

Copy Editor
Ipoger@thejewishnews.com

Danny Raskin

Senior Columnist
dannyraskin@sbcglobal.net
Columnists

George Cantor
Robin Schwartz
Ronit Pinto

JN Online

Interactive Media Director

Suzanne Sherman

ssherman W jewish.com
Online Store Manager

"I remember a patient with
psoriatic arthritis, whose
arthritis and skin psoriasis
were active, causing her a great
deal of pain and disability.
After starting on one of the
biologic agents, her arthritis
and psoriasis improved,
significantly enhancing her
quality of life."

Mindy Soble

Shelli Liebman Dorfman

Maya Brodsky
Jan Shain

"The last five or six years have
been exciting times in this field,
with a number of new drugs
coming on the market," he
adds. "These medications are
called biologic agents that block
a specific factor that naturally
occurs in the body. This factor
plays a major role in the
inflammatory process in several
types of arthritis such as
rheumatoid arthritis, psoriatic
arthritis and ankylosing
spondylitis. These medications
have been very effective in
treating these types of arthritis.

Community
Advisor), Board

Staff Writer/Columnist
hkirsbaum@thejewishnews.com

Customer Service Assts.

Shari Zingle

store@jewish.com

.

Controller

Craig R. Phipps

Editorial Director

Robert A. Sklar

IT Director

Deanna Luoma

Marketing & Circulation
Director

Kelli Baird

Departments

General Offices
248-354-6060

Circulation
248-351-5174

Classified Advertising
248-351-5100
Fax: 248-304-0049

Deadline: Tuesday, 3 p.m.
Display Advertising
Fax: 248-304-0032
Deadline: Monday, 4:30 p.m.

Editorial
Fax: 248-304-8885

Deadline: All public and social
announcements must be type- .
written, double-spaced and
received by noon Wednesday,
eight days prior to desired
date of publication.

Subscriptions:

1 year
$56
2 years
$99
Per year out-of-state ....575
Per year foreign
$142

Fulfillment

circulationdesk®thejewishnews.com
Circulation Supervisor

Barb Yessian

Circulation/
Customer Service Exec

Fenton Jones

Detroit Jewish News
29200 Northwestern Highway
Suite 110
Southfield, MI 48034

©copyright 2006
Detroit Jewish News

Our JN Mission

Dr. Lubetsky and his wife are
residents of West Bloomfield.
They are affiliated with Adat
Shalom Synagogue, where the
family is active on the social
action committee. The couple
has two adult children.

The Jewish News aspires to communicate news and opinion that's
useful, engaging, enjoyable and unique. It strives to reflect the full
range of diverse viewpoints while also advocating positions that
strengthen Jewish unity and continuity. We desire to create and
maintain a challenging, caring, enjoyable work environment that
encourages creativity and innovation. We acknowledge our role as
a responsible, responsive member of the community. Being
competitive, we must always strive to be the most respected,
outstanding Jewish community publication in the nation. Our
rewards are informed, educated readers, very satisfied advertisers,
contented employees and profitable growth.

For more information or to make an
appointment call 1-Soo-HENRYFORD or
visit our Web site www.henryford.com

1066230

10 January 12 2006

President/Publisher

F. Kevin Browett

"As with most
medical
conditions,
the earlier a
diagnosis is
made, the
more effective
the treatment
is likely to
Michael
be," he says. Lubetsky, M.1).
"This is espe-
cially true of rheumatoid
arthritis. Early intervention
with medication may slow the
progression of this disease,
preventing the joint damage
and deformity that can occur
without treatment. This can
minimize disability, allowing
patients to be able to live as
normal a life as possible.

jNonl, ,us
DETROIT JEWES.. NEWS

Arthur M. Horwitz

Chief Operating Officer

Meet one of the faces of success

Michael Lubetsky, M.D., is a
board-certified rheumatologist
at the Henry Ford Medical
Center — West Bloomfield. He
also is a member of the Henry
Ford Medical Group.

JEWISH
RE\ T , Sq

